Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 4
2010 1
2011 2
2012 2
2015 2
2016 3
2018 7
2019 8
2020 3
2021 3
2022 2
2023 4
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP. Chen N, et al. N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31340116 Clinical Trial.
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2024 May;14(4_suppl):690S-714S. doi: 10.1177/21925682241245615. Global Spine J. 2024. PMID: 38726630 Free PMC article. No abstract available.
RETRACTED: Long noncoding RNA SNHG16 promotes human retinoblastoma progression via sponging miR-140-5p.
Xu C, Hu C, Wang Y, Liu S. Xu C, et al. Biomed Pharmacother. 2019 Sep;117:109153. doi: 10.1016/j.biopha.2019.109153. Epub 2019 Jun 21. Biomed Pharmacother. 2019. Retraction in: Biomed Pharmacother. 2022 Jun;150:112857. doi: 10.1016/j.biopha.2022.112857. PMID: 31234025 Free article. Retracted.
Panels from Figure 2C appear similar to panels from Figure 2C of the article that Xiaoxia Liu, Yiyang Li, Jihong Wen, Tingting Qi and Yanli Wang have published in Biomedicine & Pharmacotherapy 125 (2020) 109882 https://doi.org/10.1016/j.biopha.2020.109882, Figure 2C of the ar …
Panels from Figure 2C appear similar to panels from Figure 2C of the article that Xiaoxia Liu, Yiyang Li, Jihong Wen, Tingting Qi and Yanli …
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefit-risk profile. ...
CONCLUSIONS: A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of …
Patient-derived xenograft models in musculoskeletal malignancies.
Lu W, Chao T, Ruiqi C, Juan S, Zhihong L. Lu W, et al. J Transl Med. 2018 Apr 23;16(1):107. doi: 10.1186/s12967-018-1487-6. J Transl Med. 2018. PMID: 29688859 Free PMC article. Review.
Despite several limitations including low take rate and long take time in PDX generation, deficient immune system and heterologous tumor microenvironment of the host, PDXs offer a more advantageous platform for preclinical drug screening, biomarker identification and clini …
Despite several limitations including low take rate and long take time in PDX generation, deficient immune system and heterologous tu …
Retraction.
[No authors listed] [No authors listed] J Cell Biochem. 2021 Nov;122 Suppl 1:S13. doi: 10.1002/jcb.29972. Epub 2021 Jun 9. J Cell Biochem. 2021. PMID: 34107072
Retraction: "Suppression of long non-coding RNA LET potentiates bone marrow-derived mesenchymal stem cells (BMSCs) proliferation by upregulating TGF-beta1," by Xin Jin, Zhiliang Zhang, Yi Lu, Zhihong Fan, J Cell Biochem. 2018; 2843-2850: The above article, published …
Retraction: "Suppression of long non-coding RNA LET potentiates bone marrow-derived mesenchymal stem cells (BMSCs) proliferation by u …
Predicament and outlook of China's math education.
Zhao W. Zhao W. Natl Sci Rev. 2020 Apr 17;7(9):1513-1517. doi: 10.1093/nsr/nwaa070. eCollection 2020 Sep. Natl Sci Rev. 2020. PMID: 34691546 Free PMC article.
Math education for the younger generation is the fundamental project to upgrade the mathematical literacy and the creativity of the whole society. China's education system has long been different from that of Western countries. China has fostered many gold medal winners of …
Math education for the younger generation is the fundamental project to upgrade the mathematical literacy and the creativity of the whole so …
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.
Aranishi T, Igarashi A, Hara K, Osumili B, Cai Z, Mizogaki A, Sato M, Takeuchi M, Minghetti A, Hunt B, Kadowaki T. Aranishi T, et al. Diabetes Ther. 2025 Mar;16(3):431-445. doi: 10.1007/s13300-024-01675-7. Epub 2024 Dec 21. Diabetes Ther. 2025. PMID: 39708085 Free PMC article.
INTRODUCTION: This analysis aimed to evaluate the long-term cost-effectiveness of tirzepatide 5 mg versus dulaglutide 0.75 mg (both administered once weekly) in people not achieving glycemic control on metformin, based on the results of the head-to-head SURPASS J-mono tria …
INTRODUCTION: This analysis aimed to evaluate the long-term cost-effectiveness of tirzepatide 5 mg versus dulaglutide 0.75 mg (both a …
40 results